To effectively generate profits, a trader must pick several companies in a sector and short the whole bunch.
ABMD has been one of the best-performing stocks in the S&P 500 over the past five years.
All the charts of the molecular diagnostics company look bullish.
Shares of the maker of health and fitness devices are near their all-time low, but buying now could pay off down the road.
Let's stand back a little and get some perspective on how prices have behaved.
At first glance, CGC's report looks like a drag, but you must dig into the weeds to see how timing and the industry are at play.
Going long on the tech giant is more about health care and credit card offerings than the iPhone.
DHR shares are up 35% in 2019.
Let's check the charts and indicators on the glucose-monitoring company.
No one knows their business as well as the CEO.